Literature DB >> 225392

Selective polymyositis inducted by coxsackievirus B1 in mice.

C G Ray, L L Minnich, P C Johnson.   

Abstract

A high-passage laboratory strain of coxsackievirus B1 produced a unique myositis that predominantly and profoundly affected hip extensors and, to a lesser extent, hindquarter knee flexors when inoculated into a strain of random-bred newborn mice of Swiss origin (COH mice). The effect was not observed in BALB/c or C3H mice similarly inoculated. In addition to the differences in susceptibility of the mouse strains, it was found that six different low-passage "field" isolates of coxsackie-virus B1 isolated from infected patients varied considerably in their capability to induce these lesions. Thus, selective myositis which is muscle group-specific can be induced in a mouse model with coxsackievirus B1, and both genetic factors of the host and characteristics of the virus strain play a significant role in the pathogenesis of the myositis.

Entities:  

Mesh:

Year:  1979        PMID: 225392     DOI: 10.1093/infdis/140.2.239

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis.

Authors:  Thomas E Morrison; Alan C Whitmore; Reed S Shabman; Brett A Lidbury; Suresh Mahalingam; Mark T Heise
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Coxsackievirus-induced disease. CD4+ cells initiate both myocarditis and pancreatitis in DBA/2 mice.

Authors:  R Blay; K Simpson; K Leslie; S Huber
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

3.  Coxsackievirus B 1-induced polymyositis. Lack of disease expression in nu/nu mice.

Authors:  S R Ytterberg; M L Mahowald; R P Messner
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

4.  Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution.

Authors:  P E Tam; R P Messner
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Variable susceptibility of mice to group B coxsackievirus infections.

Authors:  L L Minnich; C G Ray
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

6.  Molecular determinants for virulence in coxsackievirus B1 infection.

Authors:  J E Rinehart; R M Gómez; R P Roos
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

7.  Theiler's murine encephalomyelitis virus-induced cardiac and skeletal muscle disease.

Authors:  R M Gómez; J E Rinehart; R Wollmann; R P Roos
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

8.  Multiple viral determinants mediate myopathogenicity in coxsackievirus B1-induced chronic inflammatory myopathy.

Authors:  Patricia E Tam; Melissa L Weber-Sanders; Ronald P Messner
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Coxsackievirus B1-based antibody-capture enzyme-linked immunosorbent assay for detection of immunoglobulin G (IgG), IgM, and IgA with broad specificity for enteroviruses.

Authors:  C M Swanink; L Veenstra; Y A Poort; J A Kaan; J M Galama
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

10.  Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis.

Authors:  P E Tam; A M Schmidt; S R Ytterberg; R P Messner
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.